Overview
Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma
Status:
Completed
Completed
Trial end date:
2012-12-01
2012-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is an open label trial for patients currently enrolled in other perifosine trials.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
AEterna ZentarisTreatments:
Tamoxifen
Trastuzumab
Criteria
Inclusion Criteria:- Patients must be currently receiving treatment with perifosine on a previously
approved protocol.
- Patients must have had at least one evaluation following the initiation of treatment
and have stable disease, partial response or complete response.
- Patient is willing to sign a new consent Regarding the protocol no exclusion criteria
are described.